Skip to main content
. 2024 Nov 1;34:34. doi: 10.1038/s41533-024-00397-4

Fig. 1. Level of asthma control for the SABINA III population included in the analysis (N = 4556) by number of SABA prescriptions and number of SABA canisters purchased OTC.

Fig. 1

Data missing for 15 patients with 1–2 SABA prescriptions and 0 SABA OTC purchase and 1 patient with ≥3 SABA prescriptions and ≥1 SABA OTC purchase. OTC over-the-counter, SABA short-acting β2-agonist, SABINA SABA use IN Asthma.